Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar, aflibercept) in Korea
Shots: Merck allied with ISB and a consortium of companies to investigate the molecular mechanisms of SARS-CoV-2 Infection and to identify new targets for potential COVID-19 therapeutics and vaccines The collaboration supports the trial led by ISB and Swedish Medical Center in Seattle. By collecting blood and nasal swabs at different times following a patient’s […]Read More
